Inoculation of small numbers of CD44+/CD24−/low breast cancer cells in NOD/SCID mice can recapitulate the phenotypic heterogeneity of the parent tumor, whereas cells lacking the CD44+/CD24−/low marker have a greatly reduced tumor-forming capacity [3]. This evidence concerns the gene CD44 and breast carcinoma.